openPR Logo
Press release

Protheragen's FLEXFlash Platform Powers Up Next-Generation Pet Supplement Development by Offering OEM and ODM Services

12-19-2025 04:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Protheragen's FLEXFlash Platform Powers Up Next-Generation

Protheragen has launched its pet supplement OEM and ODM services anchored by its proprietary FLEXFlash platform, ushering in a new era of advanced, consumer-centric pet supplements.
As pet owners worldwide become more health-oriented towards their companions, the global pet supplement market is booming - though with some long-standing hurdles: homogenized products, inconvenient feeding procedures, and expensive, complicatedquality-checking. Taking on these challenges, Protheragen, a pioneer in pet health solutions, has launched its pet supplement OEM and ODM services [https://flexflash.protheragen.ai/] anchored by its proprietary FLEXFlash platform, ushering in a new era of advanced, consumer-centric pet supplements.

At the core of Protheragen's offering is the FLEXFlash technology, which combines low-temperaturevacuum freeze drying with rapid release formulation. This novel drying method removes moisture from active ingredients while maintaining their stability and bioactivity, andgenerates a porous framework that facilitates rapid disintegration in saliva or water. Unlike traditional supplements, FLEXFlash-powered products bypass gastrointestinal degradation and the first-pass effect, boosting bioavailability and accelerating onset. The low-moisture formula also inhibits microbial growth, eliminating the need for chemical preservatives to reduce allergy risks, while safeguarding heat-sensitive ingredients such as probiotics, enzymes, and vitamins-critical for pet health efficacy.

Backed with FLEXFlash technology, Protheragen's OEM service delivers a one-stop solution for brands, covering every stage from formula selection to finished product delivery. Leveraging over a decade of industry expertise, Protheragen can offer more than 30 scientifically validated ready-to-use formulas spanning high-demand categories: joint support, gut health, fresh breath, skin and coat care, immune system boosters, calming support, and weight management. Brands can adopt these formulas directly or customize ingredient ratios based on pet breed, age, or specific health needs, ensuring alignment with target audiences. All products are manufactured in an FDA-registered facility adhering to GMP standards, with strict quality control spanning raw material sourcing to final inspection, guaranteeing consistent safety and potency.

Complementing its OEM capabilities, Protheragen's ODM service transforms brand visions into market-ready innovations through end-to-end customization. Its expert R&D team develops exclusive formulas tailored to unique brand positioning, paired with breakthrough dosage forms that solve pet feeding struggles. These include flash-release tablets, which dissolve instantly in saliva without water or forced feeding-ideal for picky eaters, senior pets, or those with swallowing difficulties-and custom pet orally dissolving films [https://nutrapaw.protheragen.ai/custom-pet-orally-dissolving-films.html] (ODFs), which adhere to the pet's mouth and deliver precise doses in seconds. With 40+ ready-to-use ODF formulas and support for personalized labeling and packaging design, Protheragen empowers brands to stand out in a crowded market.

Protheragen's collaboration models cater to both startups and established enterprises, with scalable procurement and a mature supply chain that optimizes costs. The company's commitment to flexibility, quality, and innovation addresses the dual needs of brands-speed to market and product differentiation-while meeting pet owners' demands for safe, effective, and convenient supplements.

"As pet health evolves from a niche concern to a core consumer priority, pet supplement brands require partners that can turn ideas into impactful products," noted a Protheragen representative. "Our FLEXFlash-powered OEM and ODM services remove industry barriers, enabling brands to capitalize on market growth while putting pet wellness first." With its scientific rigor, advanced technology, and customer-centric approach, Protheragen is poised to redefine the pet supplement landscape, inviting global brands to collaborate and shape the future of pet health.

About Protheragen

Protheragen is an innovative company with FLEXFlash technology as its core competitive advantage, specializing in providing high-quality dietary supplements, pet supplements, and cosmetics. Its diverse product forms include flash-release tablets, flash-release powders, and flash-release beads, designed to meet the varying needs of different clients. With over 100 ready-to-use formulas, Protheragen can provide turnkey OEM services. If no existing formula aligns with customers' requirements, Protheragen also offers one-stop ODM services according to clients' needs.

Media Contact
Company Name: Protheragen
Contact Person: Hannah Green
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=protheragens-flexflash-platform-powers-up-nextgeneration-pet-supplement-development-by-offering-oem-and-odm-services]
Country: United States
Website: https://flexflash.protheragen.ai/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protheragen's FLEXFlash Platform Powers Up Next-Generation Pet Supplement Development by Offering OEM and ODM Services here

News-ID: 4323118 • Views:

More Releases from ABNewswire

Divorce Attorney In Arlington VA Explains Property Division In Virginia Divorces
Divorce Attorney In Arlington VA Explains Property Division In Virginia Divorces
The Irving Law Firm outlines how Virginia courts divide marital property in divorce cases. A divorce attorney in Arlington VA can help couples understand equitable distribution and what may happen to their home, savings, and other assets. Arlington, VA - An experienced divorce attorney in Arlington, VA [https://www.theirvinglawfirm.com/locations/arlington-va/], from The Irving Law Firm, is shedding light on how property division works under Virginia law. With many couples uncertain about what happens
Best Healthcare SEO Agencies for Doctors in 2026: Research Report Published by RetinaCentral.org
Best Healthcare SEO Agencies for Doctors in 2026: Research Report Published by R …
Retina Central has published a research-based comparative analysis of the Best Healthcare SEO Agencies for Doctors in 2026, examining how search visibility turns into real patient acquisition. The report evaluates agencies on local SEO performance, PPC effectiveness, website conversion, compliance awareness, reputation signals, and reporting transparency to help clinics shortlist growth partners. Miami, FL - Retina Central has published a comprehensive research article examining the best healthcare SEO agencies for doctors
Takecare Clinic Expands Healthcare Services in Bangkok
Takecare Clinic Expands Healthcare Services in Bangkok
Takecare Clinic Doctor Bangkok has expanded its healthcare services to support residents and international visitors, delivering accessible, high-quality medical care in Bangkok. BANGKOK, THAILAND - TakeCare Clinic Bangkok, a modern healthcare provider serving Thailand's bustling capital city, announces expanded medical services designed to deliver convenient, professional care to the millions of international visitors and expatriates navigating Bangkok's dynamic urban environment. With a focus on accessibility and premium service delivery, the clinic
Takecare Clinic Expands Healthcare Services in Pattaya
Takecare Clinic Expands Healthcare Services in Pattaya
Takecare Clinic Doctor Pattaya has expanded its healthcare services to better serve local residents and international visitors, providing accessible, high-quality medical care in Pattaya. PATTAYA, CHONBURI, THAILAND - TakeCare Clinic Pattaya, a leading healthcare provider in one of Thailand's most dynamic coastal cities, announces expanded medical services designed to meet the diverse healthcare needs of Pattaya's massive international tourism community. Serving millions of annual visitors alongside a substantial expatriate population, the

All 5 Releases


More Releases for Protheragen

Protheragen Expands 13C/14C-Labeled Compound Portfolio for Metabolic and Pharmac …
Protheragen offers a wider variety of 13C/14C-labeled compounds, supporting research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing. New York, USA - November 12, 2025 - Protheragen has expanded its 13C/14C-labeled compound portfolio to support research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing. The expanded lineup improves options for high-accuracy molecular tracing and supports consistent data output in metabolism and drug distribution research. Researchers can now explore a
Protheragen Introduces Comprehensive Drug Analysis Services for Pharmaceutical D …
Protheragen, a leading biotechnology company, provides effective Drug Analysis [https://www.protheragen.ai/drug-analysis.html] services that help pharmaceutical researchers and manufacturers. In drug research, drug analysis is useful for the safety, efficacy, and quality of drugs. With advanced technologies and scientific expertise, Protheragen's analytical solutions play an important role in drug development. Drug Analysis includes many analytical procedures designed to evaluate various properties of pharmaceutical compounds. These analyses are important for understanding drug characteristics and
Protheragen Launches One-stop Services for Rare Blood Diseases
Protheragen, a leading provider of life sciences research and development solutions, announces its innovative One-stop Services [https://www.protheragen.us/blood-disorders/our-services.html] platform designed to accelerate therapeutic discoveries and development across blood disease areas. This platform integrates advanced technologies with expert scientific consultation. The streamlined workflow can better address the challenges in research. "Our integrated approach allows clients to handle the issues of drug development with heightened accuracy and operational efficiency," explains a senior scientist from
Protheragen Unveils Revolutionary EndureCAR-T Trademark Cell Therapy Platform
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models. Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART Trademark technology platform, Protheragen provides investigators a wide range of disease models to ensure detailed and customized treatment methods for superior therapeutic outcomes. With the development of immunology, scientists
01-23-2025 | Health & Medicine
Getnews
Protheragen Announces GeniusAb Trademark : A Fully Human Single-Domain Antibody …
New York, United States - Protheragen has launched GeniusAb Trademark [https://www.geniusab.com/], a fully human single-domain antibody platform to produce high quality and customized antibodies for research, diagnostic and therapeutic use. This is a major breakthrough in the field of therapeutic antibodies as it is able to provide highly specific, robust, and versatile solutions to a variety of diseases. Single-domain antibodies (sdAbs), also known as VHH antibodies or camelid antibodies, are derived
Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Developme …
Protheragen announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research. Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development [https://www.protheragen.us/]. These diagnostic services are designed to support the scientific community in identifying, understanding, and ultimately treating rare diseases that affect millions